Clinical trials recruiting in Urraween, Australia
3
Recruiting trials
9
Conditions
Phase breakdown
Phase 2 1Phase 3 3
Conditions recruiting in Urraween, Australia
| Condition | Trials |
|---|---|
| Breast Neoplasm Female | 1 |
| Breast cancer | 1 |
| Chronic kidney disease | 1 |
| Cosmetic Outcome | 1 |
| End Stage Kidney Disease | 1 |
| Heart failure | 1 |
| Lung cancer | 1 |
| Non-small Cell Lung Cancer | 1 |
| Radiotherapy | 1 |
Recruiting trials in Urraween, Australia
- A Randomized Trial of Five Fraction Partial Breast Irradiation (RAPID2)
- A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
- Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
Common questions
How many clinical trials are recruiting in Urraween, Australia?
3 recruiting trials have at least one study site in Urraween, Australia.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.